International Prognostic Index score and histologic subtype for different quantile splits of HLA-DRA
. | Quantile splits* . | . | . | . | . | . | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
. | ≤ 10% . | > 10% . | ≤ 25% . | > 25% . | ≤ 50% . | > 50% . | |||||
| IPI | |||||||||||
| Low | 33 | 37 | 30 | 39 | 40 | 33 | |||||
| Low-intermediate | 33 | 27 | 35 | 25 | 26 | 30 | |||||
| High-intermediate | 21 | 21 | 25 | 19 | 21 | 20 | |||||
| High | 13 | 15 | 11 | 16 | 12 | 17 | |||||
| Histologic subtype | |||||||||||
| Centroblastic polymorphic | 12 | 19 | 18 | 18 | 18 | 18 | |||||
| Centroblastic monomorphic | 40 | 47 | 47 | 47 | 50 | 44 | |||||
| Immunoblastic | 4 | 9 | 10 | 8 | 8 | 8 | |||||
| Burkitt-like | 16 | 3 | 7 | 3 | 5 | 3 | |||||
| Plasmablastic | 12 | 4 | 5 | 4 | 3 | 6 | |||||
| Unknown/other | 16 | 18 | 13 | 19 | 16 | 20 | |||||
. | Quantile splits* . | . | . | . | . | . | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
. | ≤ 10% . | > 10% . | ≤ 25% . | > 25% . | ≤ 50% . | > 50% . | |||||
| IPI | |||||||||||
| Low | 33 | 37 | 30 | 39 | 40 | 33 | |||||
| Low-intermediate | 33 | 27 | 35 | 25 | 26 | 30 | |||||
| High-intermediate | 21 | 21 | 25 | 19 | 21 | 20 | |||||
| High | 13 | 15 | 11 | 16 | 12 | 17 | |||||
| Histologic subtype | |||||||||||
| Centroblastic polymorphic | 12 | 19 | 18 | 18 | 18 | 18 | |||||
| Centroblastic monomorphic | 40 | 47 | 47 | 47 | 50 | 44 | |||||
| Immunoblastic | 4 | 9 | 10 | 8 | 8 | 8 | |||||
| Burkitt-like | 16 | 3 | 7 | 3 | 5 | 3 | |||||
| Plasmablastic | 12 | 4 | 5 | 4 | 3 | 6 | |||||
| Unknown/other | 16 | 18 | 13 | 19 | 16 | 20 | |||||
Values are expressed as the percentage of individuals in the indicated quartile.